Source: Am J Cardiol | Posted 1 week ago Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150mg Every Two Weeks Dosing from Phase 2 Trials) ; Gaudet D, ... Doctors Guide, 6 days ago
Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol - Morningstar.com, 3 weeks ago
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014 - Wall Street Select, 4 weeks ago
3 images for "kexin"
] Landsea Green Properties (00106) said it made a successful bid jointly with Suzhou Science and Technology City Kexin Cultural and Tourism Development Company Limited for the land use rights of a parcel of land at north of Wuyi Shan Road ...4 Traders, 1 month ago Landsea (00106) & partner win bid for Rmb269m Suzhou site Etnet.com.hk, 1 month ago
Education Minister Heng Swee Keat responded last night to comments online about a photograph of former prime minister Lee Kuan Yew's 91st birthday celebration which seemed to have been altered. The photograph was uploaded on Mr Heng's Facebook page ...Asiaone, 3 days ago
Researchers from Genentech, Inc. Describe Findings in Immunoglobulins (Combined Administration of RG7652, a Recombinant Human Monoclonal Antibody...
Researchers from Genentech, Inc. Describe Findings in Immunoglobulins ( Combined Administration of RG7652 , a Recombinant Human Monoclonal Antibody Against PCSK9, and Atorvastatin Does Not Result in Reduction of Immune Function) (Combined ...) By ...4 Traders, 5 days ago
SINGAPORE - Home-grown singer Tay Kewei wants to be the next Stef Sun or JJ Lin. But before you brush her off as someone who merely thinks big, she does have a track record in realising her dreams. She once told Life! she would love to sing the ...Asiaone, 1 week ago
[September 11, 2014] (Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Sept. 11 -- The following federal patents were awarded to inventors in New York. *** ...TMC Net, 1 week ago
Summary Amgen has filed for approval the first of a new class of proteins to lower LDL cholesterol. These PCSK9 inhibitors are expected to see Amgen's evolocumab and Regeneron/Sanofi's alirocumab reach market within a year. Enough information has ...Seeking Alpha, 2 weeks ago ONLINE FIRST New opportunities for cholesterol lowering: focus on PCSK9 inhibitors Peter Sever, Judy Mackay British Journal of Cardiology, 2 months ago
The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and elevated risk of cardiovascular disease (CVD), according to the ODYSSEY ...Science Daily, 2 weeks ago New Injectable Drug Lowers LDL MedPage Today, 2 weeks ago Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY Medscape, 3 weeks ago Alirocumab drug significantly improves cholesterol levels compared to ezetimibe News-Medical.Net, 3 weeks ago
Regeneron Pharmaceuticals, Inc. and Sanofi have announced positive results from four Phase III ODYSSEY trials of alirocumab in people with hypercholesterolemia. Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein ...Individual.com, 2 weeks ago
Here's what sounds like a good idea from VC firm Index Ventures , from the latest issue of BioCentury (same one I referenced the other day ). Like many others in the biopharma venture capital world, they're trying to run the "killer experiment" as ...Corante, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!